What You Should Know:
– Fimlab Laboratories, a provider of laboratory services, research, and training, has announced a partnership with Proscia, a global leader in AI-enabled pathology solutions.
– This collaboration will leverage Proscia’s software platform to enhance Fimlab’s digital pathology capabilities and drive more precise results.
The Benefits of Digital Pathology
Digital pathology is transforming the way pathologists analyze tissue samples. By transitioning to digital images, pathologists can gain access to a wealth of data that can be analyzed using AI-powered tools. This can lead to more accurate diagnoses and improved patient outcomes.
Proscia’s Role in Digital Pathology
Proscia’s software platform offers a robust and intuitive solution for digital pathology. The platform can be used to drive all aspects of daily work, from image analysis to reporting. By leveraging AI-enabled workflows, pathologists can make more consistent interpretations of common cancer types and improve efficiency.
“Artificial intelligence is beginning to solve many of pathology’s biggest challenges,” said Teemu Tolonen, M.D., Ph.D., Chief Physician of Fimlab’s pathology department. “We carefully evaluated multiple software platforms and are confident Proscia’s will enable us to achieve a great impact from AI. Its open approach ensures we can leverage a broad variety of applications in our routine operations.”
